Pay in installments of $6.62 with
,
and
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
Promo Codes Available:
For Your Every Summer RSVP, with Code: SUMMER15
Description
ZEPBOUND Prefilled Syringe (Tirzepatide) 12.5mg .5ml Pipeline Medical Tirzepatide for Weight Loss Easy Home Treatment Levers.Health Structural insights into multiplexed pharmacological actions of tirzepatide and peptide 20 at the GIP, GLP 1 or glucagon receptors Nature Communications PhentermineTopiramate (Qsymia) Program Bellevue Growth & Recovery Peptides Telos by GLP3 Weight Loss
Shipping Notes
- Free Standard Shipping on $100+ Orders to the USA.
- Except Preorder products are shipped in 48 hours.
- Delivery to the USA:
- Standard Shipping : 3-10 business days
- If time is of the essence, please consider selecting expedited delivery for faster service.
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
4.1 ★★★★★
Based on 5 reviews
Sort
Product Reviews
★★★★★ 5
Tinta de sublimación
Color: Black
Increíble producto 100% recomendado
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on September 15, 2025
★★★★★ 5
Sublimation Ink
Color: Complete Set
The ink works great, just like the original ink that came with my printer. It was easy to order and shipped quickly.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on July 13, 2025
★★★★★ 5
Great product
Color: Black
long-lasting and gets the job done.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on November 19, 2025
★★★★★ 5
Works for us.
Color: Black
F170 - no issue and not expired (which was my only concern).
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on May 16, 2026
★★★★★ 5
Quality ink
Color: Complete Set
😊
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on October 14, 2025